Legence/Bowers deal: $325M cash upfront funded via term loan upsizing and stock issuance

The Bowers acquisition was funded with $325 million upfront cash from cash on hand, a revolver draw, a $200 million upsizing of Legence's term loan facility, and ~2.55 million Class A shares, with an additional $50 million deferred to end of 2026.

“The purchase price consisted of an upfront cash consideration of $325 million, which was funded by a combination of cash on hand, borrowings from a revolving line of credit, the $200 million upsizing of Legence’s term loan facility, and the issuance of approximately 2.55 million shares of Legence’s Class A common stock.”

Signals are extracted from public coverage and print archives and pinned to a verbatim quote, presented as reported by their sources; naming a company in a signal is not an accusation against it. The verified mark denotes a high-confidence, corroborated signal. See our methodology and legal notes.